Bruce G. Allen Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bruce G. Allen Investments’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$141K	Buy	1,429 +5	+0.4%	+$451	0.09%	108
2026 Q1	$123K	Buy	1,424 +5	+0.4%	+$438	0.08%	130
2025 Q4	$120K	Buy	1,419 +9	+0.6%	+$718	0.08%	130
2025 Q3	$102K	Buy	1,410 +6	+0.4%	+$414	0.07%	151
2025 Q2	$92K	Buy	1,404 +7	+0.5%	+$456	0.07%	165
2025 Q1	$98.6K	Buy	1,397 +6	+0.4%	+$417	0.08%	144
2024 Q4	$91.4K	Buy	1,391 +4	+0.3%	+$275	0.07%	156
2024 Q3	$97.9K	Buy	1,387 +7	+0.5%	+$488	0.08%	157
2024 Q2	$91.5K	Buy	1,380 +6	+0.4%	+$393	0.08%	158
2024 Q1	$93.3K	Sell	1,374 -2,391	-64%	-$158K	0.08%	164
2023 Q4	$233K	Buy	+3,765	New	+$221K	0.21%	61

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Bruce G. Allen Investments's IHE Position: Q2 2026 in Review

Bruce G. Allen Investments increased its iShares US Pharmaceuticals ETF (IHE) stake by 0.35% in Q2 2026, buying an estimated $451 and bringing the position to 1,429 shares worth $141K. The position accounts for 0.09% of the portfolio, ranked #108.

Bruce G. Allen Investments first reported a position in IHE in Q4 2023 and has held it in 11 quarters since. The position peaked at $233K in Q4 2023. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Bruce G. Allen Investments held 1,429 shares of iShares US Pharmaceuticals ETF worth $141K as of Q2 2026.
Bruce G. Allen Investments bought 5 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $451.
iShares US Pharmaceuticals ETF made up 0.09% of Bruce G. Allen Investments's portfolio in Q2 2026, its #108 holding.
Bruce G. Allen Investments first reported a position in iShares US Pharmaceuticals ETF in Q4 2023 and has held it in 11 quarters since.
Bruce G. Allen Investments's iShares US Pharmaceuticals ETF position peaked at $233K in Q4 2023.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.